+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Medical Affairs Outsourcing Market - Global Forecast 2026-2032- Product Image
Medical Affairs Outsourcing Market - Global Forecast 2026-2032- Product Image
Sale

Medical Affairs Outsourcing Market - Global Forecast 2026-2032

  • Report

  • 181 Pages
  • August 2026
  • Region: Global
  • 360iResearch™
  • ID: 4896732
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Medical Affairs Outsourcing Market is projected to reach USD 14.31 Billion in 2026. It is expected to continue growing at a CAGR of 15.35%, reaching USD 34.35 Billion by 2032.

Medical affairs outsourcing is moving from a tactical resourcing model to a strategic operating layer for pharmaceutical, biotechnology, and medical device companies. Demand is supported by verified structural pressures: expanding specialty and rare-disease pipelines, more complex evidence requirements from regulators and payers, rising global launch activity, and persistent need for medical information, medical writing, field medical support, publication planning, pharmacovigilance-adjacent coordination, and real-world evidence operations.

The market is shaped by internationally recognized standards such as ICH good clinical practice principles, FDA and EMA expectations for evidence generation and product communication, global transparency rules, and country-level compliance frameworks governing interactions with healthcare professionals. As medical affairs teams are increasingly accountable for scientific exchange, evidence strategy, omnichannel engagement, and post-approval value demonstration, outsourcing partners are being selected not only for cost efficiency but also for scientific depth, compliance maturity, technology enablement, and regional execution capability.

Transformative Shifts in the Medical Affairs Landscape

The medical affairs outsourcing landscape is being transformed by a shift from volume-based service delivery to integrated scientific partnership. Sponsors are increasingly seeking providers that can connect medical strategy, evidence planning, medical communications, health economics and outcomes research, and field medical operations across the product life cycle. This shift is reinforced by regulatory scrutiny of promotional boundaries and by the need for consistent, scientifically balanced information across markets.

Another defining change is the decentralization of expertise. Hybrid work models, digital scientific engagement, virtual congress formats, and remote medical information operations have widened access to specialized talent. At the same time, sponsors face tighter governance expectations, including documented review workflows, adverse event capture processes, publication ethics controls, and compliant handling of medical inquiries. Providers that combine therapeutic-area specialization with auditable quality systems are best positioned to support long-term medical affairs outsourcing engagements.

Cumulative Impact of Artificial Intelligence

Artificial intelligence is becoming a cumulative force across medical affairs outsourcing, especially in medical information triage, literature surveillance, insight mining, content modularization, and quality review support. The impact is cumulative because AI value compounds when structured data, approved content libraries, compliant workflows, and human medical review are integrated over time. Natural language processing can accelerate evidence monitoring and identify recurring scientific questions, while generative AI can support first-draft content creation when governed by validated prompts, source traceability, and expert approval.

However, AI adoption is constrained by well-documented requirements for data privacy, pharmacovigilance reporting, medical accuracy, bias mitigation, and auditability. The European Union AI Act, GDPR, FDA guidance activity on AI-enabled life sciences tools, and global cybersecurity standards are increasing the importance of transparent model governance. In medical affairs outsourcing, AI will not replace scientific accountability; it will reward providers that combine automation with medical, legal, regulatory, and quality oversight.

Key Regional Insights Across Global Markets

Asia-Pacific is one of the most dynamic regions for medical affairs outsourcing because of expanding clinical development activity, growing specialist care markets, and increasing demand for localized medical education. China, Japan, India, South Korea, and Australia each require distinct regulatory, language, and stakeholder engagement models, making regional expertise essential for scientific exchange, medical information, evidence dissemination, and compliant launch support.

North America remains a high-value outsourcing hub due to the scale of U.S. biopharmaceutical innovation, FDA-regulated communications practices, advanced real-world data infrastructure, and mature medical information models. Europe is shaped by EMA coordination, national health technology assessment requirements, GDPR, and multilingual scientific communications, all of which strengthen the role of specialized medical writing, publication, pharmacovigilance-adjacent, and value evidence providers.

Latin America, the Middle East, and Africa are gaining importance as access strategies expand and multinational sponsors pursue more consistent scientific engagement across emerging healthcare systems. Brazil and Mexico anchor much of Latin American demand, while the Middle East, particularly GCC health systems, is investing in healthcare modernization and specialty care. Across Africa, outsourcing opportunities are linked to medical education, access programs, pharmacovigilance coordination, and compliant knowledge transfer adapted to local health system capacity.

Key Group Insights for Medical Affairs Outsourcing

ASEAN is becoming increasingly relevant for medical affairs outsourcing as multinational life sciences companies adapt medical education and stakeholder engagement for diverse, multilingual, and rapidly developing healthcare systems. Providers with regional coordination capabilities can support compliant content localization, congress planning, medical information, publication support, and field medical enablement across countries with different regulatory maturity levels.

The GCC offers opportunities tied to healthcare investment, national life sciences strategies, digital health adoption, and growing demand for specialty therapies. The European Union remains a governance-intensive market where GDPR, EMA procedures, transparency rules, and national evidence expectations require disciplined medical content operations and strong quality controls. BRICS economies create scale opportunities through large patient populations, domestic innovation, expanding clinical research ecosystems, and rising demand for evidence-based care, but they also require localized regulatory and access expertise.

The G7 continues to represent premium demand for advanced medical affairs services, including real-world evidence, health economics, medical publications, and omnichannel scientific engagement. NATO member markets overlap significantly with North American and European demand centers, where security, data protection, business continuity, and cross-border operating resilience are increasingly relevant to outsourcing decisions.

Key Country Insights in Priority Markets

The United States leads demand for high-complexity medical affairs outsourcing due to its large biopharmaceutical sector, active FDA environment, robust specialty medicine market, and established expectations for medical information, publication planning, and field medical excellence. Canada offers demand tied to bilingual communications, pan-Canadian evidence needs, privacy obligations, and health technology assessment considerations, while Mexico and Brazil are important Latin American markets where localization, access support, and compliant scientific engagement are priorities.

In Europe, the United Kingdom, Germany, France, Italy, and Spain require sophisticated medical writing, market access evidence, medical information, and multilingual stakeholder engagement. Germany and France are particularly important for value demonstration because of their health technology assessment and reimbursement systems, while the United Kingdom remains influential in evidence standards through NICE and its clinical research ecosystem. Russia presents a more complex operating environment due to geopolitical, regulatory, data transfer, and compliance constraints.

China and India are major growth engines because of large patient populations, expanding clinical research activity, domestic innovation, and rising demand for medical education and scientific exchange. Japan requires highly specialized localization, stringent evidence expectations, and careful stakeholder engagement, while South Korea combines advanced digital health adoption with strong clinical research capabilities. Australia is a mature market for regional headquarters, clinical research coordination, medical governance, and evidence generation across Asia-Pacific.

Actionable Recommendations for Industry Leaders

Industry leaders should treat medical affairs outsourcing as a strategic capability rather than a transactional cost center. The highest-performing models define clear governance across medical, legal, regulatory, safety, privacy, and compliance stakeholders before work begins. Service-level agreements should include scientific quality, response accuracy, adverse event escalation, publication ethics, data protection, turnaround time, and stakeholder experience metrics.

Sponsors should prioritize partners with verified therapeutic expertise, regional regulatory knowledge, auditable quality management systems, and secure technology infrastructure. AI-enabled services should be adopted through controlled pilots that include human medical review, source validation, bias checks, cybersecurity controls, and documented approval pathways. Companies should also build global-to-local content models that allow core scientific narratives to be adapted consistently across markets without compromising compliance.

Research Methodology

This executive summary is grounded in secondary research from authoritative public sources, including regulatory agency guidance, international standards, health technology assessment frameworks, industry association publications, and peer-reviewed literature on medical affairs, real-world evidence, pharmacovigilance, compliance, and digital health. The analysis emphasizes verifiable market drivers rather than unsupported market sizing, market share, or forecasting claims.

The methodology applies triangulation across regulatory developments, healthcare system trends, sponsor operating models, outsourcing demand signals, and regional market characteristics. Insights were synthesized to identify where medical affairs outsourcing is expanding, which capabilities are becoming more strategic, and how AI, compliance, data governance, and localization are reshaping provider selection.

Conclusion

Medical affairs outsourcing is entering a more strategic phase as life sciences companies confront scientific complexity, global evidence requirements, and rising expectations for compliant stakeholder engagement. Providers that combine therapeutic expertise, regional execution, quality governance, and secure digital capabilities will become essential extensions of internal medical affairs teams.

The strongest opportunities are emerging in integrated service models that connect medical strategy, evidence generation, medical information, publications, field medical support, real-world evidence, and AI-enabled insight management. In this environment, outsourcing success will depend less on labor arbitrage and more on trust, scientific credibility, measurable quality, compliance discipline, and the ability to operate consistently across regulated global markets.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. New Revenue Opportunities
3.5. Next-Generation Business Models
3.6. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Medical Affairs Outsourcing Market, by Service Type
7.1. Introduction
7.2. Medical Audit Compliance
7.3. Medical Communications
7.3.1. Medical Education
7.3.2. Scientific Publications
7.3.3. Training
7.4. Medical Information
7.5. Medical Strategy
7.6. Medical Writing
7.6.1. Clinical Trial Writing
7.6.2. Manuscript Writing
7.6.3. Regulatory Writing
7.7. Pharmacovigilance
7.7.1. Case Processing
7.7.2. Risk Management
7.7.3. Signal Detection
8. Medical Affairs Outsourcing Market, by Therapeutic Area
8.1. Introduction
8.2. Cardiovascular
8.2.1. Arrhythmia
8.2.2. Heart Failure
8.2.3. Hypertension
8.3. Infectious Disease
8.3.1. Hepatitis
8.3.2. Respiratory Infection
8.4. Neurology
8.4.1. Alzheimer Disease
8.4.2. Parkinson Disease
8.5. Oncology
8.5.1. Breast Cancer
8.5.2. Lung Cancer
9. Medical Affairs Outsourcing Market, by Engagement Type
9.1. Introduction
9.2. Strategic Advisory Services
9.3. Operational Execution Services
9.4. Analytical & Insights Services
10. Medical Affairs Outsourcing Market, by Delivery Mode
10.1. Introduction
10.2. Hybrid
10.3. Offsite
10.4. Onsite
11. Medical Affairs Outsourcing Market, by End User
11.1. Introduction
11.2. Biotech Companies
11.3. Contract Research Organizations
11.4. Medical Device Companies
11.5. Pharmaceutical Companies
12. Medical Affairs Outsourcing Market, by Region
12.1. Asia-Pacific
12.2. North America
12.3. Latin America
12.4. Europe
12.5. Middle East
12.6. Africa
13. Medical Affairs Outsourcing Market, by Group
13.1. ASEAN
13.2. GCC
13.3. European Union
13.4. BRICS
13.5. G7
13.6. NATO
14. Medical Affairs Outsourcing Market, by Country
14.1. United States
14.2. Canada
14.3. Mexico
14.4. Brazil
14.5. United Kingdom
14.6. Germany
14.7. France
14.8. Russia
14.9. Italy
14.10. Spain
14.11. China
14.12. India
14.13. Japan
14.14. Australia
14.15. South Korea
15. Competitive Landscape
15.1. Market Share Analysis, 2025
15.2. FPNV Positioning Matrix, 2025
15.3. Market Concentration Analysis, 2025
15.3.1. Concentration Ratio (CR)
15.3.2. Herfindahl Hirschman Index (HHI)
15.4. Recent Developments & Impact Analysis, 2025
15.5. Product Portfolio Analysis, 2025
15.6. Benchmarking Analysis, 2025
16. Company Profiles
16.1. Accenture PLC
16.2. Ashfield Healthcare Communications by Inizio
16.3. Biomapas Group
16.4. Charles River Laboratories International, Inc.
16.5. Comprehend Systems, Inc. by Saama Technologies, Inc.
16.6. Excelya
16.7. Freyr Solutions
16.8. Genpact
16.9. Groupe ProductLife S.A.
16.10. ICON PLC
16.11. Indegene, Inc.
16.12. Insuvia
16.13. IQVIA Holdings, Inc.
16.14. JSS Medical Research Inc
16.15. Medpace Holdings, Inc.
16.16. MMS Holdings Inc.
16.17. PAREXEL International Corporation
16.18. Pharmalex by BlueReg
16.19. PPD, Inc. by Thermo Fischer Scientific Inc.
16.20. ProPharma Group
16.21. SGS S.A.
16.22. Syneos Health, Inc.
16.23. The Medical Affairs Company
16.24. Wuxi Clinical Development, Inc.
16.25. Zeincro Group
List of Figures
FIGURE 1. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET, YEARS CONSIDERED FOR THE STUDY
FIGURE 2. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET, RESEARCH DESIGN
FIGURE 3. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET, RESEARCH FRAMEWORK
FIGURE 4. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET, DATA TRIANGULATION
FIGURE 5. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, 2024-2032 (USD MILLION)
FIGURE 6. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2025 VS 2032 (%)
FIGURE 7. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY THERAPEUTIC AREA, 2025 VS 2032 (%)
FIGURE 9. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY THERAPEUTIC AREA, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY ENGAGEMENT TYPE, 2025 VS 2032 (%)
FIGURE 11. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY ENGAGEMENT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY DELIVERY MODE, 2025 VS 2032 (%)
FIGURE 13. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY DELIVERY MODE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 14. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY END USER, 2025 VS 2032 (%)
FIGURE 15. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 16. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 17. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 18. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 19. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 20. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
FIGURE 21. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 22. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 23. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025
List of Tables
TABLE 1. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SEGMENTATION & COVERAGE
TABLE 2. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 3. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2017-2032 (USD MILLION)
TABLE 4. GLOBAL MEDICAL AUDIT COMPLIANCE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 5. GLOBAL MEDICAL AUDIT COMPLIANCE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 6. GLOBAL MEDICAL AUDIT COMPLIANCE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 7. GLOBAL MEDICAL COMMUNICATIONS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 8. GLOBAL MEDICAL COMMUNICATIONS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 9. GLOBAL MEDICAL COMMUNICATIONS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 10. GLOBAL MEDICAL EDUCATION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 11. GLOBAL MEDICAL EDUCATION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 12. GLOBAL MEDICAL EDUCATION MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 13. GLOBAL SCIENTIFIC PUBLICATIONS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 14. GLOBAL SCIENTIFIC PUBLICATIONS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 15. GLOBAL SCIENTIFIC PUBLICATIONS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 16. GLOBAL TRAINING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 17. GLOBAL TRAINING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 18. GLOBAL TRAINING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 19. GLOBAL MEDICAL INFORMATION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 20. GLOBAL MEDICAL INFORMATION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 21. GLOBAL MEDICAL INFORMATION MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 22. GLOBAL MEDICAL STRATEGY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 23. GLOBAL MEDICAL STRATEGY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 24. GLOBAL MEDICAL STRATEGY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 25. GLOBAL MEDICAL WRITING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 26. GLOBAL MEDICAL WRITING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 27. GLOBAL MEDICAL WRITING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 28. GLOBAL CLINICAL TRIAL WRITING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 29. GLOBAL CLINICAL TRIAL WRITING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 30. GLOBAL CLINICAL TRIAL WRITING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 31. GLOBAL MANUSCRIPT WRITING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 32. GLOBAL MANUSCRIPT WRITING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 33. GLOBAL MANUSCRIPT WRITING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 34. GLOBAL REGULATORY WRITING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 35. GLOBAL REGULATORY WRITING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 36. GLOBAL REGULATORY WRITING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 37. GLOBAL PHARMACOVIGILANCE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 38. GLOBAL PHARMACOVIGILANCE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 39. GLOBAL PHARMACOVIGILANCE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 40. GLOBAL CASE PROCESSING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 41. GLOBAL CASE PROCESSING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 42. GLOBAL CASE PROCESSING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 43. GLOBAL RISK MANAGEMENT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 44. GLOBAL RISK MANAGEMENT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 45. GLOBAL RISK MANAGEMENT MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 46. GLOBAL SIGNAL DETECTION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 47. GLOBAL SIGNAL DETECTION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 48. GLOBAL SIGNAL DETECTION MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 49. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY THERAPEUTIC AREA, 2017-2032 (USD MILLION)
TABLE 50. GLOBAL CARDIOVASCULAR MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 51. GLOBAL CARDIOVASCULAR MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 52. GLOBAL CARDIOVASCULAR MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 53. GLOBAL ARRHYTHMIA MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 54. GLOBAL ARRHYTHMIA MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 55. GLOBAL ARRHYTHMIA MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 56. GLOBAL HEART FAILURE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 57. GLOBAL HEART FAILURE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 58. GLOBAL HEART FAILURE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 59. GLOBAL HYPERTENSION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 60. GLOBAL HYPERTENSION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 61. GLOBAL HYPERTENSION MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 62. GLOBAL INFECTIOUS DISEASE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 63. GLOBAL INFECTIOUS DISEASE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 64. GLOBAL INFECTIOUS DISEASE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 65. GLOBAL HEPATITIS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 66. GLOBAL HEPATITIS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 67. GLOBAL HEPATITIS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 68. GLOBAL RESPIRATORY INFECTION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 69. GLOBAL RESPIRATORY INFECTION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 70. GLOBAL RESPIRATORY INFECTION MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 71. GLOBAL NEUROLOGY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 72. GLOBAL NEUROLOGY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 73. GLOBAL NEUROLOGY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 74. GLOBAL ALZHEIMER DISEASE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 75. GLOBAL ALZHEIMER DISEASE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 76. GLOBAL ALZHEIMER DISEASE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 77. GLOBAL PARKINSON DISEASE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 78. GLOBAL PARKINSON DISEASE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 79. GLOBAL PARKINSON DISEASE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 80. GLOBAL ONCOLOGY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 81. GLOBAL ONCOLOGY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 82. GLOBAL ONCOLOGY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 83. GLOBAL BREAST CANCER MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 84. GLOBAL BREAST CANCER MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 85. GLOBAL BREAST CANCER MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 86. GLOBAL LUNG CANCER MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 87. GLOBAL LUNG CANCER MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 88. GLOBAL LUNG CANCER MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 89. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY ENGAGEMENT TYPE, 2017-2032 (USD MILLION)
TABLE 90. GLOBAL STRATEGIC ADVISORY SERVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 91. GLOBAL STRATEGIC ADVISORY SERVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 92. GLOBAL STRATEGIC ADVISORY SERVICES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 93. GLOBAL OPERATIONAL EXECUTION SERVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 94. GLOBAL OPERATIONAL EXECUTION SERVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 95. GLOBAL OPERATIONAL EXECUTION SERVICES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 96. GLOBAL ANALYTICAL & INSIGHTS SERVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 97. GLOBAL ANALYTICAL & INSIGHTS SERVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 98. GLOBAL ANALYTICAL & INSIGHTS SERVICES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 99. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY DELIVERY MODE, 2017-2032 (USD MILLION)
TABLE 100. GLOBAL HYBRID MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 101. GLOBAL HYBRID MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 102. GLOBAL HYBRID MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 103. GLOBAL OFFSITE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 104. GLOBAL OFFSITE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 105. GLOBAL OFFSITE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 106. GLOBAL ONSITE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 107. GLOBAL ONSITE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 108. GLOBAL ONSITE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 109. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 110. GLOBAL BIOTECH COMPANIES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 111. GLOBAL BIOTECH COMPANIES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 112. GLOBAL BIOTECH COMPANIES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 113. GLOBAL CONTRACT RESEARCH ORGANIZATIONS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 114. GLOBAL CONTRACT RESEARCH ORGANIZATIONS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 115. GLOBAL CONTRACT RESEARCH ORGANIZATIONS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 116. GLOBAL MEDICAL DEVICE COMPANIES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 117. GLOBAL MEDICAL DEVICE COMPANIES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 118. GLOBAL MEDICAL DEVICE COMPANIES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 119. GLOBAL PHARMACEUTICAL COMPANIES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 120. GLOBAL PHARMACEUTICAL COMPANIES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 121. GLOBAL PHARMACEUTICAL COMPANIES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 122. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 123. ASIA-PACIFIC MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 124. ASIA-PACIFIC MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2017-2032 (USD MILLION)
TABLE 125. ASIA-PACIFIC MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY MEDICAL COMMUNICATIONS, 2017-2032 (USD MILLION)
TABLE 126. ASIA-PACIFIC MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY MEDICAL WRITING, 2017-2032 (USD MILLION)
TABLE 127. ASIA-PACIFIC MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY PHARMACOVIGILANCE, 2017-2032 (USD MILLION)
TABLE 128. ASIA-PACIFIC MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY THERAPEUTIC AREA, 2017-2032 (USD MILLION)
TABLE 129. ASIA-PACIFIC MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY CARDIOVASCULAR, 2017-2032 (USD MILLION)
TABLE 130. ASIA-PACIFIC MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY INFECTIOUS DISEASE, 2017-2032 (USD MILLION)
TABLE 131. ASIA-PACIFIC MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY NEUROLOGY, 2017-2032 (USD MILLION)
TABLE 132. ASIA-PACIFIC MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY ONCOLOGY, 2017-2032 (USD MILLION)
TABLE 133. ASIA-PACIFIC MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY ENGAGEMENT TYPE, 2017-2032 (USD MILLION)
TABLE 134. ASIA-PACIFIC MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY DELIVERY MODE, 2017-2032 (USD MILLION)
TABLE 135. ASIA-PACIFIC MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 136. NORTH AMERICA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 137. NORTH AMERICA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2017-2032 (USD MILLION)
TABLE 138. NORTH AMERICA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY MEDICAL COMMUNICATIONS, 2017-2032 (USD MILLION)
TABLE 139. NORTH AMERICA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY MEDICAL WRITING, 2017-2032 (USD MILLION)
TABLE 140. NORTH AMERICA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY PHARMACOVIGILANCE, 2017-2032 (USD MILLION)
TABLE 141. NORTH AMERICA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY THERAPEUTIC AREA, 2017-2032 (USD MILLION)
TABLE 142. NORTH AMERICA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY CARDIOVASCULAR, 2017-2032 (USD MILLION)
TABLE 143. NORTH AMERICA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY INFECTIOUS DISEASE, 2017-2032 (USD MILLION)
TABLE 144. NORTH AMERICA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY NEUROLOGY, 2017-2032 (USD MILLION)
TABLE 145. NORTH AMERICA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY ONCOLOGY, 2017-2032 (USD MILLION)
TABLE 146. NORTH AMERICA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY ENGAGEMENT TYPE, 2017-2032 (USD MILLION)
TABLE 147. NORTH AMERICA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY DELIVERY MODE, 2017-2032 (USD MILLION)
TABLE 148. NORTH AMERICA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 149. LATIN AMERICA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 150. LATIN AMERICA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2017-2032 (USD MILLION)
TABLE 151. LATIN AMERICA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY MEDICAL COMMUNICATIONS, 2017-2032 (USD MILLION)
TABLE 152. LATIN AMERICA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY MEDICAL WRITING, 2017-2032 (USD MILLION)
TABLE 153. LATIN AMERICA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY PHARMACOVIGILANCE, 2017-2032 (USD MILLION)
TABLE 154. LATIN AMERICA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY THERAPEUTIC AREA, 2017-2032 (USD MILLION)
TABLE 155. LATIN AMERICA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY CARDIOVASCULAR, 2017-2032 (USD MILLION)
TABLE 156. LATIN AMERICA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY INFECTIOUS DISEASE, 2017-2032 (USD MILLION)
TABLE 157. LATIN AMERICA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY NEUROLOGY, 2017-2032 (USD MILLION)
TABLE 158. LATIN AMERICA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY ONCOLOGY, 2017-2032 (USD MILLION)
TABLE 159. LATIN AMERICA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY ENGAGEMENT TYPE, 2017-2032 (USD MILLION)
TABLE 160. LATIN AMERICA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY DELIVERY MODE, 2017-2032 (USD MILLION)
TABLE 161. LATIN AMERICA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 162. EUROPE MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 163. EUROPE MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2017-2032 (USD MILLION)
TABLE 164. EUROPE MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY MEDICAL COMMUNICATIONS, 2017-2032 (USD MILLION)
TABLE 165. EUROPE MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY MEDICAL WRITING, 2017-2032 (USD MILLION)
TABLE 166. EUROPE MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY PHARMACOVIGILANCE, 2017-2032 (USD MILLION)
TABLE 167. EUROPE MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY THERAPEUTIC AREA, 2017-2032 (USD MILLION)
TABLE 168. EUROPE MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY CARDIOVASCULAR, 2017-2032 (USD MILLION)
TABLE 169. EUROPE MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY INFECTIOUS DISEASE, 2017-2032 (USD MILLION)
TABLE 170. EUROPE MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY NEUROLOGY, 2017-2032 (USD MILLION)
TABLE 171. EUROPE MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY ONCOLOGY, 2017-2032 (USD MILLION)
TABLE 172. EUROPE MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY ENGAGEMENT TYPE, 2017-2032 (USD MILLION)
TABLE 173. EUROPE MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY DELIVERY MODE, 2017-2032 (USD MILLION)
TABLE 174. EUROPE MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 175. MIDDLE EAST MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 176. MIDDLE EAST MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2017-2032 (USD MILLION)
TABLE 177. MIDDLE EAST MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY MEDICAL COMMUNICATIONS, 2017-2032 (USD MILLION)
TABLE 178. MIDDLE EAST MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY MEDICAL WRITING, 2017-2032 (USD MILLION)
TABLE 179. MIDDLE EAST MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY PHARMACOVIGILANCE, 2017-2032 (USD MILLION)
TABLE 180. MIDDLE EAST MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY THERAPEUTIC AREA, 2017-2032 (USD MILLION)
TABLE 181. MIDDLE EAST MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY CARDIOVASCULAR, 2017-2032 (USD MILLION)
TABLE 182. MIDDLE EAST MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY INFECTIOUS DISEASE, 2017-2032 (USD MILLION)
TABLE 183. MIDDLE EAST MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY NEUROLOGY, 2017-2032 (USD MILLION)
TABLE 184. MIDDLE EAST MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY ONCOLOGY, 2017-2032 (USD MILLION)
TABLE 185. MIDDLE EAST MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY ENGAGEMENT TYPE, 2017-2032 (USD MILLION)
TABLE 186. MIDDLE EAST MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY DELIVERY MODE, 2017-2032 (USD MILLION)
TABLE 187. MIDDLE EAST MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 188. AFRICA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 189. AFRICA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2017-2032 (USD MILLION)
TABLE 190. AFRICA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY MEDICAL COMMUNICATIONS, 2017-2032 (USD MILLION)
TABLE 191. AFRICA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY MEDICAL WRITING, 2017-2032 (USD MILLION)
TABLE 192. AFRICA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY PHARMACOVIGILANCE, 2017-2032 (USD MILLION)
TABLE 193. AFRICA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY THERAPEUTIC AREA, 2017-2032 (USD MILLION)
TABLE 194. AFRICA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY CARDIOVASCULAR, 2017-2032 (USD MILLION)
TABLE 195. AFRICA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY INFECTIOUS DISEASE, 2017-2032 (USD MILLION)
TABLE 196. AFRICA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY NEUROLOGY, 2017-2032 (USD MILLION)
TABLE 197. AFRICA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY ONCOLOGY, 2017-2032 (USD MILLION)
TABLE 198. AFRICA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY ENGAGEMENT TYPE, 2017-2032 (USD MILLION)
TABLE 199. AFRICA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY DELIVERY MODE, 2017-2032 (USD MILLION)
TABLE 200. AFRICA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 201. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 202. ASEAN MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 203. ASEAN MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2017-2032 (USD MILLION)
TABLE 204. ASEAN MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY MEDICAL COMMUNICATIONS, 2017-2032 (USD MILLION)
TABLE 205. ASEAN MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY MEDICAL WRITING, 2017-2032 (USD MILLION)
TABLE 206. ASEAN MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY PHARMACOVIGILANCE, 2017-2032 (USD MILLION)
TABLE 207. ASEAN MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY THERAPEUTIC AREA, 2017-2032 (USD MILLION)
TABLE 208. ASEAN MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY CARDIOVASCULAR, 2017-2032 (USD MILLION)
TABLE 209. ASEAN MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY INFECTIOUS DISEASE, 2017-2032 (USD MILLION)
TABLE 210. ASEAN MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY NEUROLOGY, 2017-2032 (USD MILLION)
TABLE 211. ASEAN MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY ONCOLOGY, 2017-2032 (USD MILLION)
TABLE 212. ASEAN MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY ENGAGEMENT TYPE, 2017-2032 (USD MILLION)
TABLE 213. ASEAN MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY DELIVERY MODE, 2017-2032 (USD MILLION)
TABLE 214. ASEAN MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 215. GCC MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 216. GCC MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2017-2032 (USD MILLION)
TABLE 217. GCC MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY MEDICAL COMMUNICATIONS, 2017-2032 (USD MILLION)
TABLE 218. GCC MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY MEDICAL WRITING, 2017-2032 (USD MILLION)
TABLE 219. GCC MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY PHARMACOVIGILANCE, 2017-2032 (USD MILLION)
TABLE 220. GCC MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY THERAPEUTIC AREA, 2017-2032 (USD MILLION)
TABLE 221. GCC MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY CARDIOVASCULAR, 2017-2032 (USD MILLION)
TABLE 222. GCC MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY INFECTIOUS DISEASE, 2017-2032 (USD MILLION)
TABLE 223. GCC MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY NEUROLOGY, 2017-2032 (USD MILLION)
TABLE 224. GCC MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY ONCOLOGY, 2017-2032 (USD MILLION)
TABLE 225. GCC MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY ENGAGEMENT TYPE, 2017-2032 (USD MILLION)
TABLE 226. GCC MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY DELIVERY MODE, 2017-2032 (USD MILLION)
TABLE 227. GCC MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 228. EUROPEAN UNION MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 229. EUROPEAN UNION MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2017-2032 (USD MILLION)
TABLE 230. EUROPEAN UNION MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY MEDICAL COMMUNICATIONS, 2017-2032 (USD MILLION)
TABLE 231. EUROPEAN UNION MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY MEDICAL WRITING, 2017-2032 (USD MILLION)
TABLE 232. EUROPEAN UNION MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY PHARMACOVIGILANCE, 2017-2032 (USD MILLION)
TABLE 233. EUROPEAN UNION MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY THERAPEUTIC AREA, 2017-2032 (USD MILLION)
TABLE 234. EUROPEAN UNION MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY CARDIOVASCULAR, 2017-2032 (USD MILLION)
TABLE 235. EUROPEAN UNION MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY INFECTIOUS DISEASE, 2017-2032 (USD MILLION)
TABLE 236. EUROPEAN UNION MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY NEUROLOGY, 2017-2032 (USD MILLION)
TABLE 237. EUROPEAN UNION MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY ONCOLOGY, 2017-2032 (USD MILLION)
TABLE 238. EUROPEAN UNION MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY ENGAGEMENT TYPE, 2017-2032 (USD MILLION)
TABLE 239. EUROPEAN UNION MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY DELIVERY MODE, 2017-2032 (USD MILLION)
TABLE 240. EUROPEAN UNION MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 241. BRICS MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 242. BRICS MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2017-2032 (USD MILLION)
TABLE 243. BRICS MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY MEDICAL COMMUNICATIONS, 2017-2032 (USD MILLION)
TABLE 244. BRICS MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY MEDICAL WRITING, 2017-2032 (USD MILLION)
TABLE 245. BRICS MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY PHARMACOVIGILANCE, 2017-2032 (USD MILLION)
TABLE 246. BRICS MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY THERAPEUTIC AREA, 2017-2032 (USD MILLION)
TABLE 247. BRICS MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY CARDIOVASCULAR, 2017-2032 (USD MILLION)
TABLE 248. BRICS MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY INFECTIOUS DISEASE, 2017-2032 (USD MILLION)
TABLE 249. BRICS MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY NEUROLOGY, 2017-2032 (USD MILLION)
TABLE 250. BRICS MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY ONCOLOGY, 2017-2032 (USD MILLION)
TABLE 251. BRICS MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY ENGAGEMENT TYPE, 2017-2032 (USD MILLION)
TABLE 252. BRICS MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY DELIVERY MODE, 2017-2032 (USD MILLION)
TABLE 253. BRICS MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 254. G7 MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 255. G7 MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2017-2032 (USD MILLION)
TABLE 256. G7 MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY MEDICAL COMMUNICATIONS, 2017-2032 (USD MILLION)
TABLE 257. G7 MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY MEDICAL WRITING, 2017-2032 (USD MILLION)
TABLE 258. G7 MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY PHARMACOVIGILANCE, 2017-2032 (USD MILLION)
TABLE 259. G7 MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY THERAPEUTIC AREA, 2017-2032 (USD MILLION)
TABLE 260. G7 MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY CARDIOVASCULAR, 2017-2032 (USD MILLION)
TABLE 261. G7 MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY INFECTIOUS DISEASE, 2017-2032 (USD MILLION)
TABLE 262. G7 MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY NEUROLOGY, 2017-2032 (USD MILLION)
TABLE 263. G7 MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY ONCOLOGY, 2017-2032 (USD MILLION)
TABLE 264. G7 MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY ENGAGEMENT TYPE, 2017-2032 (USD MILLION)
TABLE 265. G7 MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY DELIVERY MODE, 2017-2032 (USD MILLION)
TABLE 266. G7 MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 267. NATO MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 268. NATO MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2017-2032 (USD MILLION)
TABLE 269. NATO MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY MEDICAL COMMUNICATIONS, 2017-2032 (USD MILLION)
TABLE 270. NATO MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY MEDICAL WRITING, 2017-2032 (USD MILLION)
TABLE 271. NATO MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY PHARMACOVIGILANCE, 2017-2032 (USD MILLION)
TABLE 272. NATO MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY THERAPEUTIC AREA, 2017-2032 (USD MILLION)
TABLE 273. NATO MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY CARDIOVASCULAR, 2017-2032 (USD MILLION)
TABLE 274. NATO MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY INFECTIOUS DISEASE, 2017-2032 (USD MILLION)
TABLE 275. NATO MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY NEUROLOGY, 2017-2032 (USD MILLION)
TABLE 276. NATO MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY ONCOLOGY, 2017-2032 (USD MILLION)
TABLE 277. NATO MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY ENGAGEMENT TYPE, 2017-2032 (USD MILLION)
TABLE 278. NATO MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY DELIVERY MODE, 2017-2032 (USD MILLION)
TABLE 279. NATO MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 280. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 281. UNITED STATES MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 282. UNITED STATES MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2017-2032 (USD MILLION)
TABLE 283. UNITED STATES MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY MEDICAL COMMUNICATIONS, 2017-2032 (USD MILLION)
TABLE 284. UNITED STATES MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY MEDICAL WRITING, 2017-2032 (USD MILLION)
TABLE 285. UNITED STATES MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY PHARMACOVIGILANCE, 2017-2032 (USD MILLION)
TABLE 286. UNITED STATES MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY THERAPEUTIC AREA, 2017-2032 (USD MILLION)
TABLE 287. UNITED STATES MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY CARDIOVASCULAR, 2017-2032 (USD MILLION)
TABLE 288. UNITED STATES MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY INFECTIOUS DISEASE, 2017-2032 (USD MILLION)
TABLE 289. UNITED STATES MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY NEUROLOGY, 2017-2032 (USD MILLION)
TABLE 290. UNITED STATES MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY ONCOLOGY, 2017-2032 (USD MILLION)
TABLE 291. UNITED STATES MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY ENGAGEMENT TYPE, 2017-2032 (USD MILLION)
TABLE 292. UNITED STATES MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY DELIVERY MODE, 2017-2032 (USD MILLION)
TABLE 293. UNITED STATES MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 294. CANADA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 295. CANADA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2017-2032 (USD MILLION)
TABLE 296. CANADA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY MEDICAL COMMUNICATIONS, 2017-2032 (USD MILLION)
TABLE 297. CANADA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY MEDICAL WRITING, 2017-2032 (USD MILLION)
TABLE 298. CANADA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY PHARMACOVIGILANCE, 2017-2032 (USD MILLION)
TABLE 299. CANADA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY THERAPEUTIC AREA, 2017-2032 (USD MILLION)
TABLE 300. CANADA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY CARDIOVASCULAR, 2017-2032 (USD MILLION)
TABLE 301. CANADA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY INFECTIOUS DISEASE, 2017-2032 (USD MILLION)
TABLE 302. CANADA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY NEUROLOGY, 2017-2032 (USD MILLION)
TABLE 303. CANADA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY ONCOLOGY, 2017-2032 (USD MILLION)
TABLE 304. CANADA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY ENGAGEMENT TYPE, 2017-2032 (USD MILLION)
TABLE 305. CANADA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY DELIVERY MODE, 2017-2032 (USD MILLION)
TABLE 306. CANADA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 307. MEXICO MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 308. MEXICO MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2017-2032 (USD MILLION)
TABLE 309. MEXICO MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY MEDICAL COMMUNICATIONS, 2017-2032 (USD MILLION)
TABLE 310. MEXICO MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY MEDICAL WRITING, 2017-2032 (USD MILLION)
TABLE 311. MEXICO MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY PHARMACOVIGILANCE, 2017-2032 (USD MILLION)
TABLE 312. MEXICO MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY THERAPEUTIC AREA, 2017-2032 (USD MILLION)
TABLE 313. MEXICO MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY CARDIOVASCULAR, 2017-2032 (USD MILLION)
TABLE 314. MEXICO MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY INFECTIOUS DISEASE, 2017-2032 (USD MILLION)
TABLE 315. MEXICO MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY NEUROLOGY, 2017-2032 (USD MILLION)
TABLE 316. MEXICO MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY ONCOLOGY, 2017-2032 (USD MILLION)
TABLE 317. MEXICO MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY ENGAGEMENT TYPE, 2017-2032 (USD MILLION)
TABLE 318. MEXICO MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY DELIVERY MODE, 2017-2032 (USD MILLION)
TABLE 319. MEXICO MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 320. BRAZIL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 321. BRAZIL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2017-2032 (USD MILLION)
TABLE 322. BRAZIL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY MEDICAL COMMUNICATIONS, 2017-2032 (USD MILLION)
TABLE 323. BRAZIL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY MEDICAL WRITING, 2017-2032 (USD MILLION)
TABLE 324. BRAZIL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY PHARMACOVIGILANCE, 2017-2032 (USD MILLION)
TABLE 325. BRAZIL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY THERAPEUTIC AREA, 2017-2032 (USD MILLION)
TABLE 326. BRAZIL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY CARDIOVASCULAR, 2017-2032 (USD MILLION)
TABLE 327. BRAZIL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY INFECTIOUS DISEASE, 2017-2032 (USD MILLION)
TABLE 328. BRAZIL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY NEUROLOGY, 2017-2032 (USD MILLION)
TABLE 329. BRAZIL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY ONCOLOGY, 2017-2032 (USD MILLION)
TABLE 330. BRAZIL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY ENGAGEMENT TYPE, 2017-2032 (USD MILLION)
TABLE 331. BRAZIL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY DELIVERY MODE, 2017-2032 (USD MILLION)
TABLE 332. BRAZIL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 333. UNITED KINGDOM MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 334. UNITED KINGDOM MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2017-2032 (USD MILLION)
TABLE 335. UNITED KINGDOM MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY MEDICAL COMMUNICATIONS, 2017-2032 (USD MILLION)
TABLE 336. UNITED KINGDOM MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY MEDICAL WRITING, 2017-2032 (USD MILLION)
TABLE 337. UNITED KINGDOM MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY PHARMACOVIGILANCE, 2017-2032 (USD MILLION)
TABLE 338. UNITED KINGDOM MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY THERAPEUTIC AREA, 2017-2032 (USD MILLION)
TABLE 339. UNITED KINGDOM MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY CARDIOVASCULAR, 2017-2032 (USD MILLION)
TABLE 340. UNITED KINGDOM MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY INFECTIOUS DISEASE, 2017-2032 (USD MILLION)
TABLE 341. UNITED KINGDOM MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY NEUROLOGY, 2017-2032 (USD

Companies Mentioned

  • Accenture PLC
  • Ashfield Healthcare Communications by Inizio
  • Biomapas Group
  • Charles River Laboratories International, Inc.
  • Comprehend Systems, Inc. by Saama Technologies, Inc.
  • Excelya
  • Freyr Solutions
  • Genpact
  • Groupe ProductLife S.A.
  • ICON PLC
  • Indegene, Inc.
  • Insuvia
  • IQVIA Holdings, Inc.
  • JSS Medical Research Inc
  • Medpace Holdings, Inc.
  • MMS Holdings Inc.
  • PAREXEL International Corporation
  • Pharmalex by BlueReg
  • PPD, Inc. by Thermo Fischer Scientific Inc.
  • ProPharma Group
  • SGS S.A.
  • Syneos Health, Inc.
  • The Medical Affairs Company
  • Wuxi Clinical Development, Inc.
  • Zeincro Group

Table Information

Report AttributeDetails
No. of Pages181
PublishedAugust 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 14.31 Billion
Forecasted Market Value ( USD ) by 2032 $ 34.35 Billion
Compound Annual Growth Rate15.3%
Regions CoveredGlobal
No. of Companies Mentioned25

Related Topics

Related Reports

Medical Affairs Outsourcing Market Report 2026 - Product Image

Medical Affairs Outsourcing Market Report 2026

  • Report
  • 250 Pages
  • Global
From
Medical Affairs Outsourcing - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031) - Product Image

Medical Affairs Outsourcing - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

  • Report
  • 120 Pages
  • Global
From
Healthcare Contract Research Organization Market - Global Forecast 2026-2032 - Product Image

Healthcare Contract Research Organization Market - Global Forecast 2026-2032

  • Report
  • 192 Pages
  • Global
From
Clinical Research Services Market - Global Forecast 2026-2032 - Product Image

Clinical Research Services Market - Global Forecast 2026-2032

  • Report
  • 191 Pages
  • Global
From
Healthcare Contract Research Organization (CRO) - Global Strategic Business Report - Product Image

Healthcare Contract Research Organization (CRO) - Global Strategic Business Report

  • Report
  • 174 Pages
  • Global
From

About the Medical Affairs Outsourcing Market

Medical Affairs Outsourcing is a growing segment of the healthcare services industry. It involves the outsourcing of medical affairs activities such as clinical trial management, medical writing, regulatory affairs, and pharmacovigilance. This allows pharmaceutical and biotechnology companies to focus on their core competencies while leveraging the expertise of specialized service providers. Medical Affairs Outsourcing is a cost-effective way to access the latest technology and expertise, while also providing access to a global network of medical professionals. It also helps to reduce the time and cost associated with the development of new drugs and medical devices. Companies in the Medical Affairs Outsourcing market include Parexel, ICON, Syneos Health, PRA Health Sciences, and QuintilesIMS. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.